Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Century Therapeutics (IPSC) Return on Equity (2022 - 2025)

Historic Return on Equity for Century Therapeutics (IPSC) over the last 4 years, with Q3 2025 value amounting to 0.14%.

  • Century Therapeutics' Return on Equity rose 4800.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 4800.0%. This contributed to the annual value of 0.73% for FY2024, which is 1700.0% down from last year.
  • As of Q3 2025, Century Therapeutics' Return on Equity stood at 0.14%, which was up 4800.0% from 0.1% recorded in Q2 2025.
  • Century Therapeutics' 5-year Return on Equity high stood at 0.1% for Q2 2025, and its period low was 0.74% during Q1 2024.
  • Over the past 4 years, Century Therapeutics' median Return on Equity value was 0.52% (recorded in 2023), while the average stood at 0.47%.
  • Per our database at Business Quant, Century Therapeutics' Return on Equity plummeted by -3100bps in 2024 and then surged by 6300bps in 2025.
  • Quarter analysis of 4 years shows Century Therapeutics' Return on Equity stood at 0.41% in 2022, then crashed by -64bps to 0.68% in 2023, then dropped by -5bps to 0.71% in 2024, then soared by 81bps to 0.14% in 2025.
  • Its Return on Equity stands at 0.14% for Q3 2025, versus 0.1% for Q2 2025 and 0.11% for Q1 2025.